この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Radha G.に依頼
India
Freelance Scientific Content writing, Reviewing, Proof reading and Editing - 15 + years experience - Infectious Diseases
プロフィール概要
専門分野
サービス
Writing
Technical Writing,
General Proofreading & Editing
Research
Gray Literature Search,
Scientific and Technical Research
Consulting
Scientific and Technical Consulting
職務経験
Biotechnologist - National Reference Laboratory, National Tuberculosis Elimination Program
National Institute of Research in Tuberculosis
6月 2020 - 現在 ![]()
Scientist - Chennai Cambridge collaborative study
National Institute of Research in Tuberculosis
9月 2017 - 6月 2019 ![]()
Scientist - In vitro Assay Development
Orchid Pharma Ltd
4月 2009 - 6月 2017 ![]()
Post doctoral Researcher
University of British Columbia
10月 2006 - 6月 2008 ![]()
学歴
Ph D (Immunology/ Molecular Biology/Bio-Medical Genetics) (Immunology)
National Institute of Research in Tuberculosis
7月 2000 - 9月 2006 ![]()
M. Sc Bio-Medical Genetics (Genetics)
University of Madras - Institute of Basic Medical Sciences
6月 1998 - 5月 2000 ![]()
B. Sc Zoology (Zoology)
Justice Basheer Ahmed Sayeed College for Women
6月 1995 - 5月 1998 ![]()
認定資格
出版物
JOURNAL ARTICLE
Radha Gopalaswamy, Selvakumar Subbian (2025). Intricacies of Global Tuberculosis Management—EndTB-2035 on the Fence? . Journal of Respiration.
Radha Gopalaswamy, Selvakumar Subbian (2025). Intricacies of Global Tuberculosis Management—EndTB-2035 on the Fence? . Journal of Respiration.
Radha Gopalaswamy, Bhargavi Subramanian, Manisha Parthasarathy, Chandrasekaran Padmapriyadarsini, Sivakumar Shanmugam (2025). Direct targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis from clinical samples – An update . Indian Journal of Tuberculosis.
Radha Gopalaswamy, Vivekanandhan Aravindhan, Selvakumar Subbian (2024). The Ambivalence of Post COVID-19 Vaccination Responses in Humans . Biomolecules.
Radha Gopalaswamy, Vivekanandhan Aravindhan, Selvakumar Subbian (2024). The Ambivalence of Post COVID-19 Vaccination Responses in Humans . Biomolecules.
Radha Gopalaswamy, Nishant Kumar, Himanshu Vashistha, Priya Rajendran, Jyoti Kayesth, Carel Joseph Peravali, Satabdi Kashyap, Shreeparna Ghosh, Habakkuk Yumo, Moe Moore, et al. (2023). Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India . Frontiers in Public Health.
Radha Gopalaswamy, Nandhini Palani, Dinesh Viswanathan, Bershila Preysingh, Suchithra Rajendran, Vaishnavee Vijayaraghavan, Kannadasan Thangavel, Senthil Devi Vadivel, Hannah Stanley, Kannan Thiruvengadam, et al. (2023). Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India . Medicina.
Radha Gopalaswamy, Nandhini Palani, Dinesh Viswanathan, Bershila Preysingh, Suchithra Rajendran, Vaishnavee Vijayaraghavan, Kannadasan Thangavel, Senthil Devi Vadivel, Hannah Stanley, Kannan Thiruvengadam, et al. (2023). Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India . Medicina.
Radha Gopalaswamy and Bhargavi Subramanian and Padmapriyadarsini Chandrasekaran and Siva Kumar Shanmugam(2022). An odyssey from laboratory to field ? – Portable tNGS system for TB diagnosis in programmatic setting . Indian Journal of Tuberculosis. Elsevier {BV}
Radha Gopalaswamy, V. N. Azger Dusthackeer, Silambuchelvi Kannayan, Selvakumar Subbian(2021). Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance . Journal of Respiration. 1. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 141--164. {MDPI} {AG}
(2021). Recent developments in the diagnosis and treatment of extrapulmonary non-tuberculous mycobacterial diseases . International Journal of Tuberculosis and Lung Disease.
Radha Gopalaswamy, V. N. Azger Dusthackeer, Silambuchelvi Kannayan, Selvakumar Subbian (2021). Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance . Journal of Respiration.
Radha Gopalaswamy, Harresh Adikesavalu, Ashok Kumar, Uma Devi Ranganathan, Sivakumar Shanmugam (2021). Autophagy Induction as a Host-Directed Therapeutic Strategy against <i>Mycobacterium tuberculosis</i> Infection . Medicina.
Radha Gopalaswamy, Selvakumar Subbian (2021). Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis . International Journal of Molecular Sciences.
Radha Gopalaswamy, Selvakumar Subbian (2021). Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis . International Journal of Molecular Sciences.
(2021). Pulmonary Mycobacterium abscessus and response to treatment in an outpatient setting: Case series . International Journal of Mycobacteriology.
Radha Gopalaswamy, Natarajan Ganesan, Kalamani Velmurugan, Vivekanandhan Aravindhan, Selvakumar Subbian(2020). The Strange Case of BCG and COVID-19: The Verdict Is Still up in the Air . Vaccines. 8. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 612. {MDPI} {AG}
(2020). Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment . Journal of Biomedical Science.
Kristin N Adams and Amit Kumar Verma and Radha Gopalaswamy and Harresh Adikesavalu and Dinesh Kumar Singhal and Srikanth Tripathy and Uma Devi Ranganathan and David R Sherman and Kevin B Urdahl and Lalita Ramakrishnan and Rafael E Hernandez(2019). Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance . The Journal of Infectious Diseases. 219. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1554--1558. Oxford University Press ({OUP})
Srinivasan Kandasamy and Sameer Hassan and Radha Gopalaswamy and Sujatha Narayanan(2014). Homology modelling, docking, pharmacophore and site directed mutagenesis analysis to identify the critical amino acid residue of PknI from Mycobacterium tuberculosis . Journal of Molecular Graphics and Modelling. 52. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 11--19. Elsevier {BV}
Srinivasan Kandasamy and Sameer Hassan and Radha Gopalaswamy and Sujatha Narayanan(2014). Homology modelling, docking, pharmacophore and site directed mutagenesis analysis to identify the critical amino acid residue of PknI from Mycobacterium tuberculosis . Journal of Molecular Graphics and Modelling. 52. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 11--19. Elsevier {BV}
(2013). Functional characterization of Candida albicans Hos2 histone deacetylase. F1000 Research.
(2013). Functional characterization of Candida albicans Hos2 histone deacetylase. F1000 Research.
(2009). The serine/threonine protein kinase PknI controls the growth of Mycobacterium tuberculosis upon infection. FEMS Microbiol Letters.
(2008). Mycobacterium smegmatis biofilm formation and sliding motility are affected by the serine/threonine protein kinase PknF. FEMS Microbiol Letters.
(2004). Cloning, over expression and characterization of a serine/threonine protein kinase pknI from Mycobacterium tuberculosis H37Rv. Protein Expression and Purification.
BOOK CHAPTER
Radha Gopalaswamy and Selvakumar Subbian(2022). An Update on Tuberculosis Vaccines . Vaccine Design. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 387--409. Springer {US}